文献
J-GLOBAL ID:201202221023013626
整理番号:12A1191893
限定期小細胞肺癌(LD-SCLC)治療におけるエトポシドおよびシスプラチン(EP)とEP+同時強化高分割胸部放射線療法(EP/AHTRT)へと続くイリノテカンおよびシスプラチン(IP)とを比較するランダム化第三相試験:JCOG0202
Randomized Phase III Study Comparing Etoposide and Cisplatin (EP) with Irinotecan and Cisplatin (IP) following EP plus Concurrent Accelerated Hyperfractionated Thoracic Radiotherapy (EP/AHTRT) for the Treatment of Limited-Stage Small-Cell Lung Cancer (LD-SCLC): JCOG0202
著者 (15件):
HIDA Toyoaki
(Aichi Cancer Center Hospital)
,
KUBOTA Kaoru
(National Cancer Center Hospital East)
,
ISHIKURA Satoshi
(Nagoya City Univ. Graduate School of Medical Sci.)
,
SHIBATA Taro
(National Cancer Center)
,
NISHIO Makoto
(Japanese Foundation for Cancer Res.)
,
KAWAHARA Masaaki
(Kinki-Chuo Chest Medical Center)
,
YOKOYAMA Akira
(Niigata Cancer Center Hospital)
,
IMAMURA Fumio
(Osaka Medical Center for Cancer and Cardiovascular Diseases)
,
TAKEDA Koji
(Osaka City General Hospital)
,
NEGORO Shunichi
(Hyogo Cancer Center)
,
OKAMOTO Hiroaki
(Yokohama Municipal Citizen’s Hospital)
,
YAMAMOTO Nobuyuki
(Shizuoka Cancer Center)
,
SHINKAI Tetsu
(Shikoku Cancer Center)
,
SAIJO Nagahiro
(Kinki Univ. Fac. Medicine)
,
TAMURA Tomohide
(National Cancer Center Hospital)
資料名:
日本臨床腫瘍学会学術集会プログラム・抄録集
(Abstracts. Annual Meeting of Japanese Society of Medical Oncology)
巻:
10th
ページ:
50
発行年:
2012年
JST資料番号:
L7804A
資料種別:
会議録 (C)
記事区分:
会議録記事
発行国:
日本 (JPN)
言語:
英語 (EN)